Patents by Inventor James Devlin

James Devlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170193751
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Application
    Filed: November 2, 2016
    Publication date: July 6, 2017
    Inventors: Steve Brandstetter, James Devlin
  • Patent number: 9569915
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Grant
    Filed: March 24, 2015
    Date of Patent: February 14, 2017
    Assignee: MGT GAMING, INC.
    Inventors: Steve Brandstetter, James Devlin
  • Publication number: 20150194006
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Application
    Filed: March 24, 2015
    Publication date: July 9, 2015
    Inventors: STEVE BRANDSTETTER, JAMES DEVLIN
  • Patent number: 9058715
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Grant
    Filed: August 4, 2013
    Date of Patent: June 16, 2015
    Assignee: MGT Gaming Inc.
    Inventors: Steve Brandstetter, James Devlin
  • Publication number: 20130316812
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Application
    Filed: August 4, 2013
    Publication date: November 28, 2013
    Applicant: MGT Gaming, Inc.
    Inventors: Steve Brandstetter, James Devlin
  • Patent number: 8500554
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: August 6, 2013
    Assignee: MGT Gaming, Inc.
    Inventors: Steve Brandstetter, James Devlin
  • Publication number: 20130058914
    Abstract: The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: February 28, 2012
    Publication date: March 7, 2013
    Applicant: CELERA CORPORATION
    Inventors: Olga IAKOUBOVA, James DEVLIN, Charles ROWLAND, Carmen TONG
  • Publication number: 20120302306
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Application
    Filed: August 8, 2012
    Publication date: November 29, 2012
    Applicant: MGT Gaming, Inc.
    Inventors: Steve BRANDSTETTER, James DEVLIN
  • Publication number: 20120302316
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Application
    Filed: August 8, 2012
    Publication date: November 29, 2012
    Applicant: MGT Gaming, Inc.
    Inventors: Steve BRANDSTETTER, James Devlin
  • Publication number: 20110111848
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Application
    Filed: January 14, 2011
    Publication date: May 12, 2011
    Inventors: Steve Brandstetter, James Devlin
  • Patent number: 7892088
    Abstract: A gaming system wherein a second game is triggered once a specific event occurs in a first game.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: February 22, 2011
    Inventors: Steve Brandstetter, James Devlin
  • Publication number: 20100261187
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and stroke, and genetic polymorphisms that are associated with responsiveness of an individual having a cardiovascular disorder to treatment of the disorder with statin. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: April 12, 2010
    Publication date: October 14, 2010
    Applicant: CELERA CORPORATION
    Inventors: Olga IAKOUBOVA, James DEVLIN
  • Patent number: 7799530
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and stroke, and genetic polymorphisms that are associated with responsiveness of an individual having a cardiovascular disorder to treatment of the disorder with statin. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: September 21, 2010
    Assignee: Celera Corporation
    Inventors: Olga Iakoubova, James Devlin
  • Patent number: 7695916
    Abstract: The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: April 13, 2010
    Assignee: Celera Corporation
    Inventors: Olga Iakoubova, James Devlin, Charles Rowland, Carmen Tong
  • Publication number: 20080241846
    Abstract: The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: March 21, 2008
    Publication date: October 2, 2008
    Applicant: APPLERA CORPORATION
    Inventors: Olga Iakoubova, James Devlin, Charles Rowland, Carmen Tong
  • Publication number: 20080108081
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with coronary stenosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acids and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: October 5, 2007
    Publication date: May 8, 2008
    Applicant: APPLERA CORPORATION
    Inventors: May Luke, James Devlin
  • Publication number: 20070072821
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and stroke, and genetic polymorphisms that are associated with responsiveness of an individual having a cardiovascular disorder to treatment of the disorder with statin. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: September 22, 2006
    Publication date: March 29, 2007
    Applicant: APPLERA CORPORATION
    Inventors: Olga Iakoubova, James Devlin
  • Publication number: 20070059710
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with vascular diseases, particularly stroke. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: February 25, 2005
    Publication date: March 15, 2007
    Applicant: APPLERA CORPORATION
    Inventors: May Luke, James Devlin, Michele Cargill
  • Publication number: 20070042382
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with myocardial infarction. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: March 10, 2004
    Publication date: February 22, 2007
    Applicant: APPLERA CORPORATION
    Inventors: Michele Cargill, James Devlin, Olga Iakoubova, Dov Shiffman
  • Hat
    Patent number: D1039245
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: August 20, 2024
    Inventor: James Devlin